Stratagene Expects Fourth Quarter Revenue Of Approximately $24.7 Million
2/1/2007 12:47:34 PM
LA JOLLA, Calif.--(BUSINESS WIRE)--Stratagene Corporation (Nasdaq:STGN), a developer, manufacturer and marketer of specialized life science research and diagnostic products, today announced preliminary revenue results for the fourth quarter of 2006 ended December 31, 2006. Revenue is expected to be approximately $24.7 million, an increase of 7.2% compared with pro forma revenue of $23.0 million in the fourth quarter of 2005. Full year revenue is expected to be approximately $95.6 million.